T here are few data on the prevalence of type 1 diabetes mellitus 1, 2 and no estimates for the entire Us population. the National Health and Nutrition examination survey (NHANes) is a representative cross-sectional survey of the civilian, noninstitutionalized Us population. Although NHANes does not explicitly collect information on type 1 diabetes mellitus, we estimated the prevalence based on age of diabetes diagnosis, the age of insulin initiation, and current use of insulin. 3 the protocol for the 1999-2010 NHANes was approved by the National Center for Health statistics of the Centers for Disease Control and Prevention ethics review Board. All participants gave written informed consent. After excluding 2955 infants for whom diabetes data were not collected and 75 children and adults who were missing diabetes data, 59,130 participants remained in the analytic sample. 4 We considered participants to have type 1 diabetes mellitus if they started insulin within 1 year of diabetes diagnosis, were currently using insulin and were diagnosed with diabetes under age 30 (definition 1) or under age 40 (definition 2).
Data were analyzed using sUDAAN, version 10.0 (research triangle Institute, research triangle Park, NC), accounting for the complex sampling design used in NHANes. the prevalence of diabetes (by each definition) was calculated overall and by age, race/ethnicity, and sex. the sum of sample weights was used to estimate the total number of the Us population with type 1 diabetes. We calculated the percentage of diagnosed diabetes and all diabetes (diagnosed diabetes, or hemoglobin A1c ≥6.5%, or fasting glucose ≥126 mg/dL) that was type 1.
the overall fractions (weighted number) with type 1 diabetes mellitus based on definitions 1 and 2 were 2.6/1000 (740,000 people) and 3.4/1000 (970,000 people), respectively (table). the proportions of diagnosed diabetes that were type 1 were 4.6% and 6.0%, respectively. the proportions of all diabetes that were type 1 were 3.6% and 4.8% for definitions 1 and 2, respectively. Prevalence of type 1 diabetes mellitus increased an average of 0.08% per 4 years for both definitions during the 12-year period 1999-2010 (test for trend, P = 0.02 for definition 1 and 0.06 for definition 2).
In previous estimates, the seArCH for Diabetes in Youth study 2 had identified a prevalence of 1.5/1000 (95% confidence interval [CI] = 1.5 to 1.6/1000) among youth under the age of 20-lower than our estimate of 2.4/1000 for this age group. the National survey of Children's Health found 3.2/1000 (95% CI = 2.6 to 3.7/1000) of children under the age of 18 had diabetes, although diagnosis was based on self-report and included both type 1 and type 2 diabetes. 1 Although type 1 diabetes mellitus may develop at any age, 5 estimates of the prevalence or incidence in older adults are limited. 6, 7 By definition, our estimates missed cases starting after the age of 40, while including some younger people with type 2 diabetes who required insulin within a year of diagnosis. Using a higher age cutpoint for diabetes diagnosis in our study would likely result in an even greater misclassification of type 2 diabetes as type 1. When age of diagnosis was not included in the definition (ie, when we include everyone with diabetes who started taking insulin within interaction" (there are persons for whom the outcome would occur if and only if both factors are present).
relying on standard asymptotic (large sample) theory, VanderWeele 3 recently presented a spreadsheet program to calculate sample sizes for additive interactions. still, the sampling distribution of rerI is difficult to approximate with a small-to-moderate sample size. [4] [5] [6] [7] [8] For better accuracy, I propose brute-force Monte-Carlo simulations for sample size calculations.
sAs codes are presented in the eAppendix. For cohort studies, one can specify a total of ten parameters (three parameters related to the study population, four parameters related to risks, and three parameters related to the hypothesis testing to be conducted). the three population parameters are the prevalence of the 1st factor, the prevalence of the 2nd factor, and the odds ratio between the two factors (1.0, if the two factors are independent to each other). the 4 risk parameters are: (1) the background disease risk (the disease risk for those exposed to neither factor), (2) the risk ratio comparing those exposed to the 1st but not the 2nd factor with those exposed to neither, (3) the risk ratio comparing those exposed to the 2nd but not the 1st factor with those exposed to neither, and (4) the risk ratio comparing those exposed to both factors with those exposed to neither. the three test parameters are the level of significance (α level), the target power, and the threshold of the test (zero for additive interaction, one for sufficient cause interaction, and two for singular interaction).
For case-control studies, the rare disease assumption is invoked. One can also specify a total of ten parameters. the three population parameters and the three test parameters are the same as those in cohort studies. there is no background disease risk now; one can specify the control-to-case matching ratio instead. As for the other 3 risk parameters, they are now in terms of odds ratios.
As an initial value, the program first calculates a sample size (N 0 ) using the asymptotic method. 3 
the program

Sample Size Calculations for Additive Interactions
1 year of diagnosis), the prevalence was 5.7/1000, representing an upper bound of prevalence. Ideally, diabetes status should be determined based on data collected at or before diagnosis, particularly data on diabetes autoantibodies. 8 Our prevalence estimates of type 1 diabetes mellitus in the entire civilian noninstitutionalized Us population (2.6/1000 for definition 1 and 3.4/1000 for definition 2) are reasonable given current available data. However, the limitations of these data highlight the need for more comprehensive national data collection, both to fully understand the burden of diabetes and to plan healthcare response. T here has been a growing interest in assessing interactions on the additive scale using the index of "relative excess risk due to interaction" (rerI). 1 For two dichotomous factors, rerI is defined by rr rr rr 11 10 01 1 − − + , where rr ij is the risk ratio comparing 1st factor = i and 2nd factor = j with both factors = 0. rerI is related to the potential outcome and the sufficient cause models 2 ; rerI = 0 implies no interaction on the additive scale; rerI > 1 implies "sufficient cause interaction" (there are persons for whom the outcome would occur if both factors are present but not if just one factor is present); and rerI > 2 implies "singular
